AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Food Science and Human Wellness Article
PDF (379 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Health benefits of Grifola frondosa polysaccharide on intestinal microbiota in type 2 diabetic mice

Xiaoxiang Gaoa,1, Dan Liua,1, Luying Gaob, Yuezhen Ouyanga, Yuxi Wena, Chao Aic,d, Yuqing Chena, Chao Zhaoa,e( )
College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China
Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China
School of Food Science and Engineering, South China University of Technology, Guangzhou 510641, China
Department of Food Science & Technology, National University of Singapore, Singapore 117543, Singapore
Engineering Research Centre of Fujian-Taiwan Special Marine Food Processing and Nutrition, Ministry of Education, Fuzhou 350002, China

1 The authors contributed equally to this study.Peer review under responsibility of KeAi Communications Co., Ltd.]]>

Show Author Information

Abstract

Grifola frondosa polysaccharide (GFP) as the natural compounds have been reported to exert diverse bioactivities. The aim of this study was to investigate the regulatory effects of GFP on intestinal microbiota in type 2 diabetic mice. The changes of microbiota in faeces of the diabetic mice upon high fat diet were determined and the V3 region of the 16S rRNA was sequenced by Illumina MiSeq high-throughput sequencing platform. Eighty operational taxonomic unit were identified to be shared by all samples, and the quality and richness of sequencing were assessed via rarefaction and rank abundance curves. The diversity of gut flora was slightly improved in diabetic mice after GFP treatment. The composition and relative abundance of gut microbiota at phylum and genus levels were altered by GFP. The abundance of Robinsoniella, Flavonifractor, Anaerotruncus, and Desulfvibrio were found to concentrate on diabetic mice through LEfSe analysis. Furthermore, Alloprevotella and Burkholderia had strong relevancy with other gut flora. Based on the findings, GFP might be a desired candidate on ameliorating the intestinal unbalance in diabetes.

Keywords

MaitakeGrifola frondosa polysaccharideDiabetesGut microbiota

References

[1]

Y.Q. Chen, Y.Y. Liu, M.M.R. Sarker, et al., Structural characterization and antidiabetic potential of a novel heteropolysaccharide from Grifola frondosa via IRS1/PI3K-JNK signaling pathways, Carbohydr. Polym. 198 (2018) 452-461. http://dx.doi.org/10.1016/j.carbpol.2018.06.077.
Crossref Google Scholar
[2]
B. Yuan, C. Zhao, C. Cheng, et al., A peptide-Fe(Ⅱ) complex from Grifola frondosa protein hydrolysates and its immunomodulatory activity, Food Biosci. 32 (2019) 100459. http://dx.doi.org/j.fbio.2019.100459.
[3]

C. Zhao, L.Y. Gao, C.Y. Wang, et al., Structural characterization and antiviral activity of a novel heteropolysaccharide isolated from Grifola frondosa against enterovirus 71, Carbohyd. Polym. 144 (2016) 382-389. http://dx.doi.org/10.1016/j.carbpol.2015.12.005.
Crossref Google Scholar
[4]

X.R. He, X.X. Wang, J.C. Fang, et al., Polysaccharides in Grifola frondosa mushroom and their health promoting properties: a review, Int. J. Biol. Macromol. 101 (2017) 910-921. http://dx.doi.org/10.1016/j.ijbiomac.2017.03.177.
Crossref Google Scholar
[5]

R. Martín, S. Miquel, P. Langella, et al., The role of metagenomics in understanding the human microbiome in health and disease, Virulence 5 (2014) 413-423. http://dx.doi.org/10.4161/viru.27864.
Crossref Google Scholar
[6]

R. Mesnage, M.N. Antoniou, D. Tsoukalas, et al., Gut microbiome metagenomics to understand how xenobiotics impact human health, Curr. Opin. Toxicol, 11/12 (2018) 51-58. http://dx.doi.org/10.1016/j.cotox.2019.02.002.
Crossref Google Scholar
[7]

J. Dicksved, H. Flöistrup, A. Bergström, et al., Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles, Appl. Environ. Microbiol. 73 (2007) 2284-2289. http://dx.doi.org/10.1128/aem.02223-06.
Crossref Google Scholar
[8]

C. Jernberg, S. Löfmark, C. Edlund, et al., Long-term ecological impacts of antibiotic administration on the human intestinal microbiota, ISME J. 1 (2007) 56-66. http://dx.doi.org/10.1038/ismej.2007.3.
Crossref Google Scholar
[9]

M.I. Naseer, F. Bibi, M.H. Alqahtani, et al., Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease, CNS Neurol. Disord. Drug Tar. 13 (2014) 305-311. http://dx.doi.org/10.2174/18715273113126660147.
Crossref Google Scholar
[10]

Y. Chen, D. Liu, D. Wang, et al., Hypoglycemic activity and gut microbiota regulation of a novel polysaccharide from Grifola frondosa in type 2 diabetic mice, Food Chem. Toxicol. 126 (2019) 295-302. http://dx.doi.org/10.1016/j.fct.2019.02.034.
Crossref Google Scholar
[11]

C. Zhao, C. Yang, S.T.C. Wai, et al., Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus, Crit. Rev. Food Sci. Nutr. 59 (2019) 830-847. https://doi.org/10.1080/10408398.2018.1501658.
Crossref Google Scholar
[12]

C. Zhao, Y. Wu, X. Liu, et al., Functional properties, structural studies and chemo-enzymatic synthesis of oligosaccharides, Trends Food Sci. Technol. 66 (2017) 135-145. https://doi.org/10.1016/j.tifs.2017.06.008.
Crossref Google Scholar
[13]

S. Mansour, R. Shabnam, N.M. Fatemeh, et al., Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals, Microb. Pathog. 111 (2017) 362-369. http://dx.doi.org/10.1371/journal.pone.0009085.
Crossref Google Scholar
[14]

P.D. Cani, M. Osto, L. Geurts, et al., Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity, Gut Microbes 3 (2012) 279-288. http://dx.doi.org/10.4161/gmic.19625.
Crossref Google Scholar
[15]

Q.T. Ma, Y.Q. Li, P.F. Li, et al., Research progress in the relationship between type 2 diabetes mellitus and intestinal flora, Biomed. Pharmacother. 117 (2019) 109138. http://dx.doi.org/10.1016/j.biopha.2019.109138.
Crossref Google Scholar
[16]

M.A. Hildebrandt, C. Hoffmann, S.A. Sherrill-Mix, et al., High-fat diet determines the composition of the murine gut microbiome independently of obesity, Gastroenterology 137 (2009) 1716-1724. http://dx.doi.org/10.1053/j.gastro.2009.08.042.
Crossref Google Scholar
[17]

C. Ubeda, V. Bucci, S. Caballero, et al., Intestinal microbiota containing Barnesiella species cures vancomycin-resistant enterococcus faecium colonization, Infect. Immun. 81 (2013) 965-973. http://dx.doi.org/10.1128/IAI.01197-12.
Crossref Google Scholar
[18]

R. Dziarski, S.Y. Park, D.R. Kashyap, et al., Pglyrp-regulated gut microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii enhance and Alistipes finegoldii attenuates colitis in mice, PLoS One 11 (2016) 1-24, http://dx.doi.org/10.1371/journal.pone.0146162.
Crossref Google Scholar
[19]

Y.S. Quan, K. Song, Y. Zhang, et al., Roseburia intestinalis-derived flagellin is a negative regulator of intestinal inflammation, Biochem. Biophys. Res. Commun. 501 (2018) 791-799, http://dx.doi.org/10.1371/journal.pone.0146162.
Crossref Google Scholar
[20]

U. Hofer, Microbiome: Pro-inflammatory prevotella?, Nat. Rev. Microbiol. 12 (2014) 5, http://dx.doi.org/10.1038/nrmicro3180.
Crossref Google Scholar
[21]

H.H. Chua, H.C. Chou, Y.L. Tung, et al., Intestinal dysbiosis featuring abundance of Ruminococcus gnavus associates with allergic diseases in infants, Gastroenterology 154 (2018) 154-167, http://dx.doi.org/10.1053/j.gastro.2017.09.006.
Crossref Google Scholar
[22]

M.A. Cotta, T.R. Whitehead, E. Falsen, et al., Robinsoniella peoriensis gen. nov., sp. nov., isolated from a swine-manure storage pit and a human clinical source, Int. J. Syst. Evol. Microbiol. 59 (2009) 150-155. http://dx.doi.org/10.1095/biolreprod57.4.901.
Crossref Google Scholar
[23]

A. Blosse, P. Lehours, K.T. Wilson, et al., Helicobacter: inflammation, immunology and vaccines, Helicobacter 22 (2017) e12517. http://dx.doi.org/10.1111/hel.12406.
Crossref Google Scholar
[24]

A.C. Senok, H. Verstraelen, M. Temmerman, et al., Probiotics for the treatment of bacterial vaginosis, Cochrane Database Syst. Rev. 4 (2009) CD006289. http://dx.doi.org/10.1002/14651858.CD006289.pub2.
Crossref Google Scholar
[25]

P. Gajer, R.M. Brotman, G. Bai, et al., Temporal dynamics of the human vaginal microbiota, Sci. Transl. Med. 4 (2012) 132ra52. http://dx.doi.org/10.1126/scitranslmed.3003605.
Crossref Google Scholar
[26]

K. Faust, J. Raes, Microbial interactions: from networks to models, Nat. Rev. Microbiol. 10 (2012) 538-550. http://dx.doi.org/10.1038/nrmicro2832.
Crossref Google Scholar
Food Science and Human Wellness
Volume 11 Issue 1,
January 2022
Pages 68-73
DOI: 10.1016/j.fshw.2021.07.008
Cite this article:
Gao X, Liu D, Gao L, et al. Health benefits of Grifola frondosa polysaccharide on intestinal microbiota in type 2 diabetic mice. Food Science and Human Wellness, 2022, 11(1): 68-73. https://doi.org/10.1016/j.fshw.2021.07.008

594

Views

44

Downloads

21

Crossref

18

Web of Science

18

Scopus

0

CSCD

Altmetrics
Received: 29 March 2020
Revised: 10 June 2020
Accepted: 16 June 2020
Published: 11 September 2021
© 2021 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return